Advertisement

Executives at Medtronic issue an update on the medical device company's Symplicity renal denervation device for treating high blood pressure.

Medtronic

Medtronic (NYSE:MDT) executives yesterday updated analysts on its device for treating high blood pressure, a renal denervation system called Symplicity, laying out the timetable for its hypertension program.

In renal denervation, a catheter is inserted in to the renal arteries to ablate the nerves lining those vessels, which play a role in regulating blood pressure.

It's a hot market in medtech these days, as Fridley, Minn.-based Medtronic vies with Boston Scientific (NYSE:BSX) and cross-town rival St. Jude Medical (NYSE:STJ) and smaller players.

Advertisement
Advertisement